Selected article for: "atrial fibrillation and mean age"

Author: Cantarutti, Nicoletta; Battista, Virginia; Adorisio, Rachele; Cicenia, Marianna; Campanello, Claudia; Listo, Elisa; Campana, Andrea; Trocchio, Gianluca; Drago, Fabrizio
Title: Cardiac Manifestations in Children with SARS-COV-2 Infection: 1-Year Pediatric Multicenter Experience
  • Cord-id: k7445gzq
  • Document date: 2021_8_23
  • ID: k7445gzq
    Snippet: Since the spread of COVID-19, pediatric patients were initially considered less affected by SARS-COV-2, but current literature reported subsets of children with multisystem inflammatory syndrome (MIS-C). This study aims to describe the cardiac manifestation of SARS-COV-2 infection in a large cohort of children admitted to two Italian pediatric referral centers. Between March 2020 and March 2021, we performed a cardiac evaluation in 294 children (mean age 9 ± 5.9 years, male 60%) with active or
    Document: Since the spread of COVID-19, pediatric patients were initially considered less affected by SARS-COV-2, but current literature reported subsets of children with multisystem inflammatory syndrome (MIS-C). This study aims to describe the cardiac manifestation of SARS-COV-2 infection in a large cohort of children admitted to two Italian pediatric referral centers. Between March 2020 and March 2021, we performed a cardiac evaluation in 294 children (mean age 9 ± 5.9 years, male 60%) with active or previous SARS-COV-2 infection. Twenty-six showed ECG abnormalities: 63 repolarization anomalies, 13 Long QTc, five premature ventricular beats, two non-sustained ventricular tachycardia, and one atrial fibrillation. In total, 146 patients underwent cardiac biomarkers: NT-proBNP was elevated in 57, troponin in 34. An echocardiogram was performed in 98, showing 54 cardiac anomalies: 27 left-ventricular dysfunction, 42 pericarditis, 16 coronaritis. MIS-C was documented in 46 patients (mean age 9 ± 4.8 years, male 61%) with cardiac manifestations in 97.8%: 27 ventricular dysfunctions, 32 pericarditis, 15 coronaritis, 3 arrhythmias. All patients recovered, and during follow-up, no cardiac anomalies were recorded. Our experience showed that cardiac involvement is not rare in children with SARS-COV-2, and occurred in almost all patients with MIS-C. However, patients’ recovery is satisfactory and no additional events were reported during FU.

    Search related documents:
    Co phrase search for related documents
    • acute phase and long term follow study: 1
    • acute phase and long term prognosis: 1
    • acute phase and long term sequelae: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute phase and low molecular weight: 1, 2, 3, 4, 5, 6, 7
    • acute phase and low molecular weight heparin: 1, 2, 3, 4, 5, 6
    • acute phase and low percentage: 1, 2
    • acute phase and lv dysfunction: 1, 2, 3, 4
    • acute phase and lv function: 1, 2, 3, 4, 5, 6, 7
    • acute phase and lv function recovery: 1, 2
    • acute phase and lv systolic dysfunction: 1, 2, 3, 4
    • acute phase and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • long term follow and low molecular weight: 1
    • long term follow and low molecular weight heparin: 1
    • long term follow and lv dysfunction: 1, 2, 3, 4
    • long term follow and lv function: 1, 2
    • long term follow and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • low molecular weight and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8
    • low molecular weight heparin and magnetic resonance: 1, 2, 3
    • low percentage and magnetic resonance: 1, 2